Overview

Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of ONO-2333Ms in patients with Recurrent Major Depressive Disorder
Phase:
Phase 2
Details
Lead Sponsor:
Ono Pharma USA Inc